The Microdose

The Microdose

Home
This Week in Psychedelics
5 Questions
Spotlight
Opinion
Podcast
Archive
About

February 2026

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use
Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuroscience gets FDA Breakthrough…
 • Anna Marie Yanny
What should you listen to while tripping?: 5 Questions with auditory neuroscientist Nikolas Francis
Francis discusses how mice on psilocybin reveal the brain’s responses to sounds.
 • Shayla Love
Compass announces promising yet modest results from second Phase 3 psilocybin trial; Missouri hearings on ibogaine and psilocybin bills, New…
Plus: Helus’s DMT formulation shows promise in treating depression and Compass laying groundwork for COMP360 trigger law in Vermont
 • jane c. hu
A bonanza of new state psychedelics bills, including ones to fund ibogaine research and new trigger laws for synthetic psilocybin
Plus: A death and other troubles at ibogaine centers in Mexico, and MAPS releases policy guidebook
 • jane c. hu
Dreaming While Under: 5 Questions with anesthesiologist Harrison Shong-Wen Chow
Chow discusses how dreams during surgery have relieved trauma symptoms.
 • Shayla Love
Legislative updates in Mississippi, West Virginia, Oregon, and New Hampshire; Fast-tracked federal approval of Compass's synthetic…
Plus: Definium (formerly MindMed) hit with “trade secret” lawsuit; and an analysis of ibogaine experiences
 • jane c. hu
Psychedelic narcissism: 5 Questions for psychotherapy researcher Henrik Jungaberle
Jungaberle discusses how the drugs famous for ego-death can also reinforce the ego.
 • Shayla Love

January 2026

© 2026 UC Berkeley Center for the Science of Psychedelics · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture